A Study to Investigate Differences in the Extent and Rate of Absorption of Doxylamine/Pyridoxine From 2 Different Products Under Fasting Conditions

NCT03905564 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Sponsor decision

Conditions

Bioavailability

Interventions

DRUG: doxylamine succinate 10 mg/pyridoxine hydrochloride 10 mg combination
DRUG: Diclegis (Registered Trademark)

Sponsor

Grünenthal GmbH

Collaborators

[object Object]